BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 16086045)

  • 61. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.
    Passweg JR; Rabusin M; Musso M; Beguin Y; Cesaro S; Ehninger G; Espigado I; Iriondo A; Jost L; Koza V; Lenhoff S; Lisukov I; Locatelli F; Marmont A; Philippe P; Pilatrino C; Quartier P; Stary J; Veys P; Vormoor J; Wahlin A; Zintl F; Bocelli-Tyndall C; Tyndall A; Gratwohl A;
    Br J Haematol; 2004 Jun; 125(6):749-55. PubMed ID: 15180864
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Allogeneic blood stem cell transplantation.
    Ehninger G; Bornhäuser M
    Eur J Cancer; 2009 Sep; 45 Suppl 1():412-3. PubMed ID: 19775651
    [No Abstract]   [Full Text] [Related]  

  • 63. Is blood a better source of allogeneic hematopoietic stem cells for use after radiation accidents?
    Frickhofen N; Körbling M; Fliedner TM
    Bone Marrow Transplant; 1996 Feb; 17(2):131-5. PubMed ID: 8640157
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The A-B-C of haematopoietic stem cell transplantation.
    Rafeah NT; Fadilah SA
    Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Why are there regional differences in stem cell transplantation activity? An EBMT analysis.
    Gratwohl A; Baldomero H; Frauendorfer K; Niederwieser D; ;
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S7-S10. PubMed ID: 18724308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Autologous stem cell transplantation for systemic sclerosis.
    Farge D; Nash R; Laar JM
    Autoimmunity; 2008 Dec; 41(8):616-24. PubMed ID: 18958754
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
    Bailey HK; Kappy MS; Giller RH; Gralla J
    Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
    [TBL] [Abstract][Full Text] [Related]  

  • 71. EBMT survey on bone marrow transplant activity in Europe: regional differences.
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1994 Jun; 13(6):683-8. PubMed ID: 7920292
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Stem cell transplantation in Europe: trends and prospects.
    Tan SS; Uyl-de Groot CA; Huijgens PC; Fibbe WE
    Eur J Cancer; 2007 Nov; 43(16):2359-65. PubMed ID: 17919900
    [TBL] [Abstract][Full Text] [Related]  

  • 73. High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.
    Buser AS; Stern M; Bucher C; Arber C; Heim D; Halter J; Meyer-Monard S; Stussi G; Lohri A; Ghielmini M; Tichelli A; Passweg JR; Gratwohl A
    Bone Marrow Transplant; 2007 Mar; 39(6):335-40. PubMed ID: 17342158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Complete autologous bone marrow recovery after allogeneic stem cell transplantation in a child with acute monoblastic leukemia].
    Balwierz W; Chełmecka-Hanusiewic L; Klekawka T; Wójcik B; Kowalczyk JR; Ksiazek T
    Przegl Lek; 2010; 67(6):425-6. PubMed ID: 21344774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias.
    Passweg JR; Rabusin M
    Autoimmunity; 2008 Dec; 41(8):660-5. PubMed ID: 18958755
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survey on haematopoietic stem cell transplantation for children in Europe.
    Miano M; Cancedda R; Hartmann O; Cornish J; Locatelli F; Egeler RM; Slavin S; Veys P; Ortega J; Peters C; Wynn RF; Iori AP; Fagioli F; Ljungmann P; Niethammer D; Bordigoni P; Dini G;
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S3-8. PubMed ID: 15812526
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of high-dose therapy and hematopoietic stem cell transplantation for mantle cell lymphoma.
    Laudi N; Arora M; Burns L; McGlave P; Miller J; Bohac G; Rogers T; Barker J; Coad J; Weisdorf D
    Am J Hematol; 2006 Jul; 81(7):519-24. PubMed ID: 16755570
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Hematopoietic stem cell transplantation (HSCT): characteristics of HSCT using bone marrow, peripheral blood and cord blood cells].
    Sakamaki H
    Rinsho Ketsueki; 2003 May; 44(5):283-93. PubMed ID: 12822402
    [No Abstract]   [Full Text] [Related]  

  • 79. Autologous and allogeneic hematopoietic stem cell transplantation for Multiple Sclerosis: perspective on mechanisms of action.
    Van Wijmeersch B; Sprangers B; Dubois B; Waer M; Billiau AD
    J Neuroimmunol; 2008 Jul; 197(2):89-98. PubMed ID: 18541311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.